Has antifungal susceptibility testing come of age

Cited by (361)

Items 101–200 of 361

1. Effectiveness of Anidulafungin in Eradicating Candida Species in Invasive Candidiasis
   Michael A. Pfaller, Daniel J. Diekema, Linda B. Boyken, Shawn A. Messer, Shailesh Tendolkar, Richard J. Hollis, Beth P. Goldstein · 2005 · Antimicrobial Agents and Chemotherapy
2. Susceptibility testing of fungi to antifungal drugs
   Sanguinetti, Maurizio, Posteraro, Brunella · 2018 · Journal of Fungi
3. The Investigational Agent E1210 Is Effective in Treatment of Experimental Invasive Candidiasis Caused by Resistant Candida albicans
   N. Wiederhold, L. Najvar, A. Fothergill, Dora I. McCarthy, R. Bocanegra, M. Olivo, W. Kirkpatrick, M. Everson, F. Duncanson, T. Patterson · 2014 · Antimicrobial Agents and Chemotherapy
4. In Vitro Susceptibility of Filamentous Fungal Isolates From a Corneal Ulcer Clinical Trial
   Prajna Lalitha, Catherine Q. Sun, Namperumalsamy Venkatesh Prajna, Rajarathinam Karpagam, Manoharan Geetha, Kieran Sunanda O’Brien, Vicky Cevallos, Stephen D. McLeod, Nisha R. Acharya, Thomas M. Lietman · 2013 · American Journal of Ophthalmology
5. Pharmacokinetic/pharmacodynamic modeling can help guide targeted antimicrobial therapy for nosocomial gram-negative infections in critically ill patients
   John Mohr, Audrey R. Wanger, John H. Rex · 2004 · Diagnostic Microbiology and Infectious Disease
6. Amphotericin Bin vitroresistance is associated with fatalAspergillus flavusinfection
   Inès Hadrich, Fattouma Makni, Sourour Neji, F. Cheikhrouhou, Hatem Bellâaj, Moez Elloumi, Ali Ayadi, Stéphane Ranque · 2012 · Medical Mycology
7. Organism, Minimum Inhibitory Concentration, and Outcome in a Fungal Corneal Ulcer Clinical Trial
   Prajna Lalitha, Namperumalsamy Venkatesh Prajna, Catherine E. Oldenburg, Muthiah Srinivasan, Tiruvengada Krishnan, Jeena Mascarenhas, C. M. Vaitilingam, Stephen D. McLeod, Michael E. Zegans, Travis C. Porco et al. · 2012 · Cornea
8. Evaluation of the Etest and Disk Diffusion Methods for Determining Susceptibilities of 235 Bloodstream Isolates of Candida glabrata to Fluconazole and Voriconazole
   Michael A. Pfaller, Daniel J. Diekema, Linda B. Boyken, Shawn A. Messer, Shailesh Tendolkar, Richard J. Hollis · 2003 · Journal of Clinical Microbiology
9. Multiple OralCandidaInfections in Patients with Sjögren’s Syndrome — Prevalence and Clinical and Drug Susceptibility Profiles
   Zhimin Yan, Andrew Young, Hong Hua, Yanying Xu · 2011 · The Journal of Rheumatology
10. Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification
    David S. Perlin, Nathan P. Wiederhold · 2017 · The Journal of Infectious Diseases
11. In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia
    J. Chandenier, Koffi Daho Adoubryn, C. Douchet, B. Sar, Maryvonne Kombila, D. Swinne, M. Thérizol‐Ferly, Yves Buisson, D Richard-Lenoble · 2004 · European Journal of Clinical Microbiology & Infectious Diseases
12. Emerging Issues in Antifungal Resistance
    John R. Perfect, Mahmoud Afif Ghannoum · 2020 · Infectious Disease Clinics of North America
13. Validation of 24-Hour Fluconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Results from a Global Candida Antifungal Surveillance Program
    Michael A. Pfaller, Linda B. Boyken, Richard J. Hollis, Jennifer S. Kroeger, Shawn A. Messer, Shailesh Tendolkar, Daniel J. Diekema · 2008 · Journal of Clinical Microbiology
14. Candida parapsilosis complex water isolates from a haemodialysis unit: biofilm production and in vitro evaluation of the use of clinical antifungals
    Regina Helena Pires, Jaime Maia dos Santos, José Eduardo Zaia, Carlos Henrique Gomes Martins, Maria José Soares Mendes‐Giannini · 2011 · Memórias do Instituto Oswaldo Cruz
15. Candida Resistance and Its Clinical Relevance
    Michael E. Klepser · 2006 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
16. Susceptibility Test Methods: Yeasts and Filamentous Fungi
    Elizabeth M. Johnson, Maiken Cavling Arendrup · 2015 · ASM Press eBooks
17. Antimicrobial Susceptibility Testing of Bacteria of Veterinary Origin
    Jeffrey L. Watts, Michael T. Sweeney, Brian V. Lubbers · 2018 · Microbiology Spectrum
18. Rationale for Reading Fluconazole MICs at 24 Hours Rather than 48 Hours When Testing Candida spp. by the CLSI M27-A2 Standard Method
    Luis Ostrosky‐Zeichner, John H. Rex, Michael A. Pfaller, Daniel J. Diekema, Barbara Dudley Alexander, David R. Andes, Steven D. Brown, Vishnu P. Chaturvedi, Mahmoud Afif Ghannoum, Cindy C. Knapp et al. · 2008 · Antimicrobial Agents and Chemotherapy
19. Prophylaxis and treatment of invasive candidiasis in the intensive care setting
    Luis Ostrosky‐Zeichner · 2004 · European Journal of Clinical Microbiology & Infectious Diseases
20. Primary Cutaneous Mucormycosis Caused by Rhizomucor variabilis in an Immunocompetent Patient
    Zhao Ying, Qiangqiang Zhang, Li Li, Junhao Zhu, Kefei Kang, Lianjun Chen · 2009 · Mycopathologia
21. Treatment of onychomycosis in an era of antifungal resistance: Role for antifungal stewardship and topical antifungal agents
    Aditya Kumar Gupta, Boni Elizabeth Elewski, Warren S. Joseph, Shari R. Lipner, C. Ralph Daniel, Antonellá Tosti, Eric Guenin, Mahmoud Afif Ghannoum · 2024 · Mycoses
22. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies
    Elizabeth M. Johnson, Ana Espinel‐Ingroff, Adrien Székely, Hans P. Hockey, Peter F. Troke · 2008 · International Journal of Antimicrobial Agents
23. Diagnosis and management of cryptococcal meningitis in HIV-infected adults
    Thomas C McHale, David R. Boulware, John Kasibante, Kenneth Ssebambulidde, Caleb P Skipper, Mahsa Abassi · 2023 · Clinical Microbiology Reviews
24. Methodological Issues in Antifungal Susceptibility Testing of Malassezia pachydermatis
    Andrea Peano, Mario Pasquetti, Paolo Tizzani, Elisa Chiavassa, Jacques Guillot, Elizabeth M. Johnson · 2017 · Journal of Fungi
25. Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?
    Bassetti, M., Vena, A., Bouza, E., Peghin, M., Muñoz, P., Righi, E., Pea, F., Lackner, M., Lass-Flörl, C. · 2020 · Clinical Microbiology and Infection
26. In Vitro Pharmacodynamics of Anidulafungin and Caspofungin against Candida glabrata Isolates, Including Strains with Decreased Caspofungin Susceptibility
    Jason M. Cota, Michael Carden, John R. Graybill, Laura K. Najvar, David S. Burgess, Nathan P. Wiederhold · 2006 · Antimicrobial Agents and Chemotherapy
27. Role of antifungal susceptibility testing in patient management
    Graeme N. Forrest · 2006 · Current Opinion in Infectious Diseases
28. A General Overview on Past, Present and Future Antimycotics~!2009-11-01~!2010-04-06~!2010-06-24~!
    Geert Van Minnebruggen, Isabelle François, Bruno P.A. Cammue, Karin Thevissen, Valérie Vroome, Marcel J. Borgers, B. Shroot · 2010 · The Open Mycology Journal
29. Global Genomic Characterization of Salmonella enterica Serovar Telelkebir
    Yu-Feng Qiu, Reshma B. Nambiar, Xuebin Xu, Shun-tai Weng, Hang Pan, Kuicheng Zheng, Min Yue · 2021 · Frontiers in Microbiology
30. ANTIFUNGAL SUSCEPTIBILITY TESTING: CURRENT ROLE FROM THE CLINICAL LABORATORY PERSPECTIVE
    Brunella Posteraro, Riccardo Torelli, Elena De Carolis, Patrizia Posteraro, Maurizio Sanguinetti · 2014 · Mediterranean Journal of Hematology and Infectious Diseases
31. FKS2 Mutations Associated with Decreased Echinocandin Susceptibility of Candida glabrata following Anidulafungin Therapy
    Sofia Costa‐de‐Oliveira, Isabel Marcos Miranda, Raquel Monteiro Silva, Ana P. Silva, Rita Rocha, António Amorim, Acácio Gonçalves Rodrigues, Cidália Pina‐Vaz · 2010 · Antimicrobial Agents and Chemotherapy
32. Molecular Diagnostics forMycobacterium tuberculosisInfection
    Kristen V. Dicks, Jason E. Stout · 2018 · Annual Review of Medicine
33. Fungal Spectrum Identified by a New Slide Culture andIn VitroDrug Susceptibility Using Etest in Fungal Keratitis
    Wen-Ya Qiu, Yu‐Feng Yao, Yefei Zhu, Yongming Zhang, Ping Zhou, Yiqi Jin, Bei Zhang · 2005 · Current Eye Research
34. Anidulafungin: an echinocandin antifungal
    Michael A. Pfaller · 2004 · Expert Opinion on Investigational Drugs
35. Fluconazole Resistance among Oral Candida Isolates from People Living with HIV/AIDS in a Nigerian Tertiary Hospital
    Iriagbonse I. Osaigbovo, Patrick Lofor, Rita Okeoghene Oladele · 2017 · Journal of Fungi
36. Efficacy of terbinafine and itraconazole in different doses and in combination in the treatment of tinea infection: A randomized controlled parallel group open labeled trial with clinico-mycological correlation
    Najuma Subba, SatyendraK Singh, Ragini Tilak · 2020 · Indian Journal of Dermatology
37. Evaluation by Data Mining Techniques of Fluconazole Breakpoints Established by the Clinical and Laboratory Standards Institute (CLSI) and Comparison with Those of the European Committee on Antimicrobial Susceptibility Testing (EUCAST)
    Isabel Cuesta, Concha Bielza, Manuel Cuenca‐Estrella, Pedro Larrañaga, Juan L. Rodrı́guez-Tudela · 2010 · Antimicrobial Agents and Chemotherapy
38. In vitro Susceptibility Testing in Aspergillus Species: An Update
    Cornelia Lass‐Flörl · 2010 · Future Microbiology
39. Validation of 24-Hour Posaconazole and Voriconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Application of Epidemiological Cutoff Values to Results from a Global Candida Antifungal Surveillance Program
    Michael A. Pfaller, Linda B. Boyken, Richard J. Hollis, Jennifer S. Kroeger, Shawn A. Messer, Shailesh Tendolkar, Daniel J. Diekema · 2011 · Journal of Clinical Microbiology
40. Correlation between Etest®, disk diffusion, and microdilution methods for antifungal susceptibility testing of Candida species from infection and colonization
    Melyssa Negri, Mariana Henriques, Terezinha Inez Estivalet Svidzinski, Claudete Rodrigues Paula, Rosário Oliveira · 2009 · Journal of Clinical Laboratory Analysis
41. The real crisis in antimicrobial resistance: failure to anticipate and respond
    Bonomo, Robert A, Perez, Federico, Hujer, Andrea M, Hujer, Kristine M, Vila, Alejandro J · 2024 · Clinical Infectious Diseases
42. Interactions of Yeasts, Moulds, and Antifungal Agents
    Gerri S. Hall · 2011 · Humana Press eBooks
43. The Epidemiology of Invasive Candidiasis
    Michael A. Pfaller, Daniel J. Diekema · 2014 · ASM Press eBooks
44. Diagnose und Therapie von Pilzinfektionen und der Pneumozystis-Pneumonie bei Kindern und Jugendlichen mit neoplastischen Erkrankungen
    Andreas H. Groll, Joerg Ritter · 2005 · Klinische Pädiatrie
45. Antifungal pharmacotherapy for neonatal candidiasis
    Joseph M. Bliss, Melanie A. Wellington, Francis Gigliotti · 2003 · Seminars in Perinatology
46. Data Mining Validation of Fluconazole Breakpoints Established by the European Committee on Antimicrobial Susceptibility Testing
    Isabel Cuesta, Concha Bielza, Pedro Larrañaga, Manuel Cuenca‐Estrella, Fernando Laguna, Dolors Rodríguez-Pardo, Benito Almirante, Albert Pahissa, Juan L. Rodrı́guez-Tudela · 2009 · Antimicrobial Agents and Chemotherapy
47. Evaluation of the NCCLS M44-P Disk Diffusion Method for Determining Susceptibilities of 276 Clinical Isolates of Cryptococcus neoformans to Fluconazole
    Michael A. Pfaller, Shawn A. Messer, Linda B. Boyken, C. Rice, Shailesh Tendolkar, Richard J. Hollis, Daniel J. Diekema · 2004 · Journal of Clinical Microbiology
48. Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections
    Kathleen M. Job, Jared A Olson, Chris R. Stockmann, Jonathan E. Constance, Elena Yu. Enioutina, Joseph E. Rower, Matthew W. Linakis, Alfred H. Balch, Yu Tian, Xiaoxi Liu et al. · 2016 · Expert Review of Anti-infective Therapy
49. The future of fungal susceptibility testing
    Brunella Posteraro, Maurizio Sanguinetti · 2014 · Future Microbiology
50. In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia
    Soukeina Gheith, Fatma Saghrouni, Wadiaa Bannour, Yosra Ben Youssef, Abderrahim Khélif, Anne‐Cécile Normand, Renaud Piarroux, Moncef Ben Saïd, Mansour Njah, Stéphane Ranque · 2014 · SpringerPlus
51. Update from the Laboratory
    Mohammad Tahseen Al Bataineh, Deanna A. Sutton, Annette W. Fothergill, Nathan P. Wiederhold · 2015 · Infectious Disease Clinics of North America
52. Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients
    I. Mohammédi, M. A. Piens, Christophe Padoin, Dominique Robert · 2005 · European Journal of Clinical Microbiology & Infectious Diseases
53. Stenusine, an antimicrobial agent in the rove beetle genus Stenus (Coleoptera, Staphylinidae)
    Inka Lusebrink, Konrad Dettner, Karlheinz Seifert · 2008 · Die Naturwissenschaften
54. Rapid flow-cytometric susceptibility testing of Candida species
    Bernard Rudensky, Ellen Broidie, Amos M. Yinnon, Tanya Weitzman, Esther Paz, Nathan Keller, David Raveh · 2004 · Journal of Antimicrobial Chemotherapy
55. Clinical and Microbiological Characteristics of Breakthrough Candidemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients in a Japanese Hospital
    Muneyoshi Kimura, Hideki Araoka, Hisashi Yamamoto, Yuki Asano‐Mori, Shigeki Nakamura, Satoshi Yamagoe, Hideaki Ohno, Yoshitsugu Miyazaki, Masahiro Abe, Mitsuhiro Yuasa et al. · 2017 · Antimicrobial Agents and Chemotherapy
56. Recent advances in antifungal pharmacotherapy for invasive fungal infections
    Jason C Gallagher, Conan MacDougall, Elizabeth S. Dodds Ashley, John R. Perfect · 2004 · Expert Review of Anti-infective Therapy
57. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis
    Shang­rong Fan, X. P. Liu · 2010 · Mycoses
58. Treatment Outcomes of Secondarily Impetiginized Pediatric Atopic Dermatitis Lesions and the Role of Oral Antibiotics
    Jeffrey Bryant Travers, Amal Kozman, Yongxue Yao, Wenyu Ming, Weiguo Yao, Mathew J. Turner, Mark H. Kaplan, Nico Mousdicas, Anita N. Haggstrom, Chandan Saha · 2011 · Pediatric Dermatology
59. Molecular Markers of Antifungal Resistance: Potential Uses in Routine Practice and Future Perspectives
    Guillermo García‐Effrón · 2021 · Journal of Fungi
60. Moxifloxacin Susceptibility Mediates the Relationship between Causative Organism and Clinical Outcome in Bacterial Keratitis
    Catherine E. Oldenburg, Prajna Lalitha, Muthiah Srinivasan, Mathivathana Palanisamy, M. Jayahar Bharathi, Revathi Rajaraman, Meenakshi Ravindran, Jeena Mascarenhas, Natalie Nardone, Kathryn J. Ray et al. · 2013 · Investigative Ophthalmology & Visual Science
61. Utility of real-time antifungal susceptibility testing for fluconazole in the treatment of candidemia
    John W. Baddley, Mukesh Patel, Marga Jones, Gretchen A. Cloud, Anita C. Smith, Stephen A. Moser · 2004 · Diagnostic Microbiology and Infectious Disease
62. The Pharmacodynamics of Antimicrobial Agents
    Marilyn N. Martinez, Pierre‐Louis Toutain, John D. Turnidge · 2013
63. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance
    Mario Fernández‐Ruiz, Jesús Guinea, David Lora, Óscar Zaragoza, Mireia Puig‐Asensio, Benito Almirante, Manuel Cuenca‐Estrella, José María Aguado, B. Padilla, Patricia Muñóz et al. · 2017 · Clinical Microbiology and Infection
64. Reasons for antimicrobial treatment failures and predictive value of in-vitro susceptibility testing in veterinary practice: An overview
    Angelika Richter, Andrea T. Feßler, A. Böttner, Lydia Mareen Köper, Jürgen Wallmann, Štefan Schwarz · 2020 · Veterinary Microbiology
65. Drug resistance in fungi - an emerging problem
    Arunaloke Chakrabarti · 2011
66. The Evolving Role of Antifungal Susceptibility Testing
    Gregory A. Eschenauer, Peggy L. Carver · 2013 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
67. Intracutaneous pharmacokinetics of oral antifungals and their relevance in recalcitrant cutaneous dermatophytosis: Time to revisit basics
    Pooja Arora, Kabir Sardana, Khushbu Mahajan · 2017 · Indian Journal of Dermatology Venereology and Leprology
68. Meningitis due toPrototheca wickerhamii: rare case in China
    Qiang-Qiang Zhang, Liping Zhu, Xinhua Weng, Li Li, Jiajun Wang · 2006 · Medical Mycology
69. Mechanisms of resistance against allylamine and azole antifungals in Trichophyton: A renewed call for innovative molecular diagnostics in susceptibility testing
    Aditya Kumar Gupta, Tong Wang, Avantika Mann, Vincent Piguet, Anuradha Chowdhary, Wayne L. Bakotic · 2025 · PLoS Pathogens
70. Efficacy of Noncarbapenem β-Lactams Compared to Carbapenems for Extended-Spectrum β-Lactamase–Producing Enterobacterales Urinary Tract Infections
    Daniel T. Anderson, Benjamin Albrecht, K. Ashley Jones, Jesse T. Jacob, Mary Elizabeth Sexton, Zanthia Wiley, William C. Dube, Benjamin Lee, Sujit Suchindran · 2022 · Open Forum Infectious Diseases
71. Therapeutic Guidelines in Systemic Fungal Infections
    Richardson, Jones Bl · 2003
72. Comparison of the Semisolid Agar Antifungal Susceptibility Test with the NCCLS M38-P Broth Microdilution Test for Screening of Filamentous Fungi
    Çiğdem Kuzucu, Barbara Rapino, Laura A. McDermott, Susan Hadley · 2004 · Journal of Clinical Microbiology
73. Correspondence of In Vitro and In Vivo Fluconazole Dose-Response Curves for Cryptococcus neoformans
    Robert A. Larsen, Madeline Bauer, Ann Thomas, Alejandro Sanchez, Diane M. Citron, Meri Rathbun, Thomas Stephen Harrison · 2005 · Antimicrobial Agents and Chemotherapy
74. Overcoming Antibiotic Resistance with Novel Paradigms of Antibiotic Selection
    George V. Tetz, Victor Tetz · 2022 · Microorganisms
75. Synthesis, characterization, and in vitro activity against Candida spp. of fluconazole encapsulated on cationic and conventional nanoparticles of poly(lactic-co-glycolic acid)
    Nicolás Sebastián Gómez, Rodrigo Gonzalo Torres, Claudia Cristina Ortiz López · 2017 · Nanotechnology Science and Applications
76. Analysis of Empiric Antimicrobial Strategies for Cellulitis in the Era of Methicillin-Resistant Staphylococcus aureus
    Suzanne M. Phillips, Conan MacDougall, David A. Holdford · 2007 · Annals of Pharmacotherapy
77. The Ins and Outs of Azole Antifungal Drug Resistance: Molecular Mechanisms of Transport
    Martin Zavřel, Brooke D. Esquivel, Theodore C. White · 2017 · Springer eBooks
78. Comparison of Broth Dilution and Disc Diffusion Method for the Antifungal Susceptibility Testing of Aspergillus flavus
    Ravi Kumar, Sandeep Kumar Shrivastava, Arunaaloke Chakraborti · 2010 · American Journal of Biomedical Sciences
79. Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience
    Wirawan Jeong, Peter Haywood, Naranie Shanmuganathan, Julian Lindsay, Karen F. Urbancic, Michelle R. Ananda-Rajah, Wen Chen, Ashish R. Bajel, David Ritchie, Andrew Grigg et al. · 2016 · Journal of Antimicrobial Chemotherapy
80. Issues in antifungal stewardship: an opportunity that should not be lost: Table 1
    Chand Wattal, Arunaloke Chakrabarti, Jaswinder Kaur Oberoi, J. Peter Donnelly, Rosemary A. Barnes, Banke Lal Sherwal, Neeraj Goel, Sonal Saxena, George M. Varghese, Rajeev N. Soman et al. · 2016 · Journal of Antimicrobial Chemotherapy
81. Effects of Antifungal Interventions on the Outcome of Experimental Infections with Phenotypic Switch Variants ofCryptococcus neoformans
    Bettina C. Fries, Emily Cook, Xiabo Wang, Arturo Casadevall · 2004 · Antimicrobial Agents and Chemotherapy
82. Susceptibility Test Methods: General Considerations
    John D. Turnidge, Mary Jane Ferraro, James H. Jorgensen · 2011
83. A Collaborative Tale of Diagnosing and Treating Chronic Pulmonary Aspergillosis, from the Perspectives of Clinical Microbiologists, Surgical Pathologists, and Infectious Disease Clinicians
    Paige M. K. Larkin, Ashrit Multani, Omer Eugene Beaird, Ayrton J. Dayo, Gregory A. Fishbein, Shangxin Yang · 2020 · Journal of Fungi
84. Molecular Principles of Antifungal Drug Resistance
    Dominique Sanglard, Theodore C. White · 2014 · ASM Press eBooks
85. EUCAST and CLSI: How to Assess in Vitro Susceptibility and Clinical Resistance
    Ana Alastruey‐Izquierdo, Manuel Cuenca‐Estrella · 2012 · Current Fungal Infection Reports
86. Species distribution and antifungal susceptibility patterns of Candida species: Is low susceptibility to itraconazole a trend in Malaysia?
    Jacinta Santhanam, Nazmiah Nazmiah, Muhammad Nazri Aziz · 2013 · PubMed
87. Molecular identification and in-vitro antifungal susceptibility testing of Candida species isolated from patients with onychomycosis
    Keyvan Pakshir, Kamiar Zomorodian, Alireza Zakaei, Marjan Motamedi, Moosa Rahimi Ghiasi, Mohsen Karamitalab · 2015 · Current Medical Mycology
88. Antifungal Susceptibility of Yeasts and Filamentous Fungi by CLSI Broth Microdilution Testing
    Wiederhold, Nathan P. · 2023 · Methods in Molecular Biology
89. Human Cutaneous Protothecosis: A Case Report and Review of Cases from Mainland China, Hong Kong, and Taiwan
    Fang Wang, Peiying Feng, Yimin Lin, Xiaohong Chen, Dandan Xu, Zhuo Wang, Jiande Han · 2018 · Mycopathologia
90. Resistance Patterns and Clinical Significance of Candida Colonization and Infection in Combat-Related Injured Patients From Iraq and Afghanistan
    Dana M Blyth, Katrin Mende, Amy Weintrob, Miriam L. Beckius, Wendy C. Zera, William Pierre Litherland Bradley, Dan Z. Lu, David R. Tribble, Clinton K. Murray · 2014 · Open Forum Infectious Diseases
91. In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH2 alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans
    Francesco Barchiesi, Andrea Giacometti, Oscar Cirioni, Daniela Arzeni, Carmela Silvestri, Wojciech Kamysz, Alessandra Abbruzzetti, Alessandra Riva, Elżbieta Kamysz, Giorgio Scalise · 2007 · Peptides
92. Clinical utility of antifungal susceptibility testing
    Todd P McCarty, Paul M. Luethy, John W. Baddley, Peter G. Pappas · 2022 · JAC-Antimicrobial Resistance
93. Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India
    Murugesan Vanathi, Ravinder Naik, Navneet Sidhu, Nishat Hussain Ahmed, Noopur Gupta, Radhika Tandon · 2022 · Indian Journal of Ophthalmology
94. A Review of Antifungal Susceptibility Testing for Dermatophyte Fungi and It’s Correlation with Previous Exposure and Clinical Responses
    Sidra Saleem Khan, Roderick J. Hay, Ditte Marie Lindhardt Saunte · 2022 · Journal of Fungi
95. Hazards Associated with the Combined Application of Fungicides and Poultry Litter in Agricultural Areas
    Dario Corrêa-Junior, Cláudio Ernesto Taveira Parente, Susana Frasés · 2024 · Journal of Xenobiotics
96. Direct fluconazole susceptibility testing of positive Candida blood cultures by flow cytometry
    Bernard Rudensky, Ellen Broide, Nathanel Berko, Yonit Weil‐Weiner, Amos M. Yinnon, David Raveh · 2007 · Mycoses
97. Candida glabrata: Multidrug Resistance and Increased Virulence in a Major Opportunistic Fungal Pathogen
    Michael A. Pfaller, Mariana Castanheira, Shawn R. Lockhart, Ronald N. Jones · 2012 · Current Fungal Infection Reports
98. Antifungal Susceptibility Testing
    Annette W. Fothergill, Michael G. Rinaldi, Deanna A. Sutton · 2006 · Infectious Disease Clinics of North America
99. Vulvovaginal Candidiasis due to non albicans Candida: its species distribution and antifungal susceptibility profile
    Sachin Chandrakant Deorukhkar, Santosh Saini · 2013
100. A Systematic Screen Reveals a Diverse Collection of Medications That Induce Antifungal Resistance in Candida Species
     Arielle Butts, Parker Reitler, Andrew T. Nishimoto, Christian A. DeJarnette, Leanna R. Estredge, Tracy L. Peters, Michael P. Veve, Phillip David Rogers, Glen E. Palmer · 2019 · Antimicrobial Agents and Chemotherapy